cellvie featured in Biocentury's Emerging Company Profile
Harvard spinout cellvie is pioneering therapeutic mitochondria
transplantation as a way to rescue cell energy metabolism and
save cells that would otherwise die.
James McCully, a cellvie AG co-founder, developed the approach
at Harvard Medical School to ameliorate ischemia-reperfusion
injury, which is the tissue damage caused when blood supply
returns after a period of ischemia.